GlobeNewswire Inc.··Kirby Mcinerney LlpSoleno Therapeutics Faces Federal Securities Lawsuit Over Drug Safety Misrepresentations
Federal class action filed against $SLNO over alleged safety misrepresentations of DCCR drug. Stock fell 39% after safety revelations; investor deadline May 5, 2026.
SLNOsecurities class actionlead plaintiff deadline